Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1353912rdf:typepubmed:Citationlld:pubmed
pubmed-article:1353912lifeskim:mentionsumls-concept:C1123023lld:lifeskim
pubmed-article:1353912lifeskim:mentionsumls-concept:C0085112lld:lifeskim
pubmed-article:1353912lifeskim:mentionsumls-concept:C1332717lld:lifeskim
pubmed-article:1353912lifeskim:mentionsumls-concept:C1706438lld:lifeskim
pubmed-article:1353912lifeskim:mentionsumls-concept:C0039194lld:lifeskim
pubmed-article:1353912lifeskim:mentionsumls-concept:C0450127lld:lifeskim
pubmed-article:1353912lifeskim:mentionsumls-concept:C0085358lld:lifeskim
pubmed-article:1353912lifeskim:mentionsumls-concept:C0035015lld:lifeskim
pubmed-article:1353912lifeskim:mentionsumls-concept:C0680727lld:lifeskim
pubmed-article:1353912lifeskim:mentionsumls-concept:C1332714lld:lifeskim
pubmed-article:1353912lifeskim:mentionsumls-concept:C1413244lld:lifeskim
pubmed-article:1353912lifeskim:mentionsumls-concept:C2698600lld:lifeskim
pubmed-article:1353912lifeskim:mentionsumls-concept:C1882923lld:lifeskim
pubmed-article:1353912lifeskim:mentionsumls-concept:C1548437lld:lifeskim
pubmed-article:1353912pubmed:issue2lld:pubmed
pubmed-article:1353912pubmed:dateCreated1992-9-8lld:pubmed
pubmed-article:1353912pubmed:abstractTextWe analyzed the role of CD4+ and CD8+ T cells in H-2-disparate skin allograft rejection in the mutant mouse strain C.B-17/Icr scid with severe combined immunodeficiency. On the day of skin allografting, scid mice were adoptively transferred with negatively selected CD4+ or CD8+ splenocytes from normal unsensitized C.B-17/Icr mice. These populations were obtained using a double-mAb--plus--complement elimination protocol using anti-CD4 or anti-CD8 mAb that resulted in no detectable CD4+ or CD8+ cells by FACS and negligible numbers of cytolytic T lymphocytes by limiting dilution analysis in anti-CD8 treated populations. Spleen cells were removed from grafted mice at the time of rejection and were tested in vitro for antidonor reactivity in several assays: mixed lymphocyte culture, cell-mediated lympholysis, and LDA for CTL and for IL-2-producing HTL. The presence of Thy 1.2+, CD4+, or CD8+ cells was determined by FACS. All control C.B-17 mice and scid mice adoptively transferred with nondepleted CD4+, and CD8+ cells rejected skin allografts with similar mean survival times (15.6 +/- 1.5, 18.8 +/- 3.4, 18.0 +/- 5.4, respectively), whereas control scid mice retain skin allografts indefinitely (all greater than 100 days). C.B-17 syngeneic grafts survived indefinitely in all groups. At the time of rejection, splenocytes from scid mice receiving CD4+ cells had negligible donor-specific cytotoxicity in CML and negligible numbers of CTL by LDA, but demonstrated a good proliferative response in MLC and IL-2-producing cells by LDA (frequency = 1/1764). There were no detectable CD8+ cells present by FACS analysis. Conversely, splenocytes from scid mice adoptively transferred with CD8+ cells had strong donor-specific cytotoxicity in CML (58.8% +/- 16.1%) and CTL by LDA (frequency = 1/3448), but no significant proliferation was detected in MLC. There were no detectable CD4+ cells by FACS, but there were small numbers of IL-2-producing cells by LDA (frequency = 1/10,204). These data demonstrate that CD4+ cells adoptively transferred into scid mice are capable of mediating skin allograft rejection in the absence of any detectable CD8+ cells or significant functional cytolytic activity. The adoptive transfer of CD8+ cells also results in skin allograft rejection in the absence of detectable CD4+ cells. The detection of small numbers of IL-2 secreting cells in these mice may indicate that CD(8+)-mediated allograft rejection in this model is dependent on IL-2-secreting CD8+ cells.lld:pubmed
pubmed-article:1353912pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1353912pubmed:languageenglld:pubmed
pubmed-article:1353912pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1353912pubmed:citationSubsetIMlld:pubmed
pubmed-article:1353912pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1353912pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1353912pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1353912pubmed:statusMEDLINElld:pubmed
pubmed-article:1353912pubmed:monthAuglld:pubmed
pubmed-article:1353912pubmed:issn0041-1337lld:pubmed
pubmed-article:1353912pubmed:authorpubmed-author:UchiyamaKKlld:pubmed
pubmed-article:1353912pubmed:authorpubmed-author:HantoD WDWlld:pubmed
pubmed-article:1353912pubmed:authorpubmed-author:SheltonM WMWlld:pubmed
pubmed-article:1353912pubmed:authorpubmed-author:WalpL ALAlld:pubmed
pubmed-article:1353912pubmed:authorpubmed-author:BaslerJ TJTlld:pubmed
pubmed-article:1353912pubmed:issnTypePrintlld:pubmed
pubmed-article:1353912pubmed:volume54lld:pubmed
pubmed-article:1353912pubmed:ownerNLMlld:pubmed
pubmed-article:1353912pubmed:authorsCompleteYlld:pubmed
pubmed-article:1353912pubmed:pagination278-86lld:pubmed
pubmed-article:1353912pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:1353912pubmed:meshHeadingpubmed-meshheading:1353912-...lld:pubmed
pubmed-article:1353912pubmed:meshHeadingpubmed-meshheading:1353912-...lld:pubmed
pubmed-article:1353912pubmed:meshHeadingpubmed-meshheading:1353912-...lld:pubmed
pubmed-article:1353912pubmed:meshHeadingpubmed-meshheading:1353912-...lld:pubmed
pubmed-article:1353912pubmed:meshHeadingpubmed-meshheading:1353912-...lld:pubmed
pubmed-article:1353912pubmed:meshHeadingpubmed-meshheading:1353912-...lld:pubmed
pubmed-article:1353912pubmed:meshHeadingpubmed-meshheading:1353912-...lld:pubmed
pubmed-article:1353912pubmed:meshHeadingpubmed-meshheading:1353912-...lld:pubmed
pubmed-article:1353912pubmed:meshHeadingpubmed-meshheading:1353912-...lld:pubmed
pubmed-article:1353912pubmed:meshHeadingpubmed-meshheading:1353912-...lld:pubmed
pubmed-article:1353912pubmed:meshHeadingpubmed-meshheading:1353912-...lld:pubmed
pubmed-article:1353912pubmed:meshHeadingpubmed-meshheading:1353912-...lld:pubmed
pubmed-article:1353912pubmed:meshHeadingpubmed-meshheading:1353912-...lld:pubmed
pubmed-article:1353912pubmed:meshHeadingpubmed-meshheading:1353912-...lld:pubmed
pubmed-article:1353912pubmed:year1992lld:pubmed
pubmed-article:1353912pubmed:articleTitleMediation of skin allograft rejection in scid mice by CD4+ and CD8+ T cells.lld:pubmed
pubmed-article:1353912pubmed:affiliationDepartment of Surgery, Washington University School of Medicine, St. Louis, Missouri 63110.lld:pubmed
pubmed-article:1353912pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1353912pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1353912lld:pubmed